Skip to main content
Top

20-02-2017 | Non-melanoma skin cancer | Article

Giant adenoid basal cell carcinoma of the scalp with intracranial involvement—successful management strategies for a rare entity

Journal: European Journal of Plastic Surgery

Authors: Mona Ascha, Amy Hiuser, Melissa Piliang, Graham S. Schwarz

Publisher: Springer Berlin Heidelberg

Abstract

Adenoid basal cell carcinoma (BCC) is a rare but aggressive histologic subtype of BCC. The aim of this report is to present our multidisciplinary management strategy and a literature review on this seldom reported entity. A 72-year-old female with fungating giant BCC of the scalp, ear, and bone underwent preoperative biopsy revealing adenoid histology with infiltrating and nodular components. The patient underwent radical resection of the biparietal and occipital scalp, auriculectomy and craniectomy with dural resection. Immediate reconstruction of the intracranial and bony defect was performed with dural substitute and a titanium cranioplasty. The soft tissue defect was reconstructed with a latissimus dorsi free flap and split thickness skin graft using the right superficial temporal artery and vein as recipient vessels. Adjuvant external beam radiation was initiated postoperatively. Nearly 2 years postoperatively, she presented mesh exposure necessitating secondary reconstruction with debridement, hardware removal, and an anterolateral thigh (ALT) free flap, followed by flap debulking. Four years following initial presentation, she remains disease-free. To our knowledge, this is the only reported case of a giant, locally invasive scalp BCC with the adenoid subtype treated with composite resection and single stage reconstruction. Using an aggressive multimodal management paradigm, treatment and surveillance of the rarely reported, giant, locally invasive scalp BCC with adenoid subtype can result in a durable disease-free response and a functional, esthetic reconstruction. Evidence-based medicine level.
Level of Evidence: Level V, therapeutic study.
Literature
1.
Burch MB, Chung TK, Rosenthal EL, Schmalbach CE (2015) Multimodality management of high-risk head and neck basal cell carcinoma requiring free-flap reconstruction. Otolaryngol Head Neck Surg 152(5):868–873CrossRefPubMed
2.
Hill GJ (1992) American Joint Committee on Cancer Classification for Melanoma. J Clin Oncol 10(2):345–346
3.
Herring SM (1994) Giant adenoid basal cell carcinoma. Ann Plast Surg 32:544–547CrossRefPubMed
4.
Archontaki M, Stavrianos S, Korkolis D, Arnogiannaki N, Vassiliadis V, Liapakis I, Christ H, Rapidis A, Kokkalis G (2009) Giant basal cell carcinoma: clinicopathological analysis of 51 cases and review of the literature. Anticancer Res 29:2655–2664PubMed
5.
Netscher DT, Spira M (2004) Basal cell carcinoma: an overview of tumor biology and treatment. Plast Reconstr Surg 113:74–94CrossRef
6.
Kinhikar RA, Tambe CM, Patil K et al (2014) Estimation of dose enhancement to soft tissue due to backscatter radiation near metal interfaces during head and neck radiothearpy—a phantom dosimetric study with radiochromic film. J Med Phys 39(1):40–43CrossRefPubMedPubMedCentral